Shandong Sinobioway Biomedicine Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Sinobioway Biomedicine has a total shareholder equity of CN¥2.5B and total debt of CN¥117.2M, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are CN¥2.8B and CN¥282.7M respectively.
Key information
4.7%
Debt to equity ratio
CN¥117.20m
Debt
Interest coverage ratio | n/a |
Cash | CN¥318.05m |
Equity | CN¥2.52b |
Total liabilities | CN¥282.68m |
Total assets | CN¥2.80b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002581's short term assets (CN¥676.9M) exceed its short term liabilities (CN¥259.7M).
Long Term Liabilities: 002581's short term assets (CN¥676.9M) exceed its long term liabilities (CN¥22.9M).
Debt to Equity History and Analysis
Debt Level: 002581 has more cash than its total debt.
Reducing Debt: 002581's debt to equity ratio has reduced from 42.4% to 4.7% over the past 5 years.
Debt Coverage: 002581's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002581's interest payments on its debt are well covered by EBIT.